Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
549 - A company is entering into a new disease state in which they don't already market a product in Canada.If they produce a corporate ad (pre NOC) indicating that they are now entering into the therapeutic area/disease state, can they mention the therapeutic area/disease state in the ad?
-
In the context of a corporate message, a company can discuss the areas in which it is doing research regardless of whether it has an approved product for that condition. There are regulatory provisions you need to be aware of when creating such pieces. For example, as per C.08.002 of the Food and Drug Regulations, advertising must not allude to products which have not yet been approved for use in Canada. The PAAB preclearance system will help you discuss the therapeutic area in a manner which is consistent with the regulations. As a general comment, a message that “Company X is doing research in condition Y” would enable you to accomplish your stated goal.
